Cargando…
Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis C
A few studies have shown that methotrexate (MTX) use exacerbates liver fibrosis and even leads to liver cirrhosis in rheumatoid arthritis (RA) patients, although the risk is low compared to psoriatics. We therefore conducted a population-based cohort study to investigate the impact of long-term MTX...
Autores principales: | Tang, Kuo-Tung, Chen, Yi-Hsing, Lin, Ching-Heng, Chen, Der-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016832/ https://www.ncbi.nlm.nih.gov/pubmed/27609026 http://dx.doi.org/10.1038/srep33104 |
Ejemplares similares
-
Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B
por: Tang, Kuo-Tung, et al.
Publicado: (2016) -
Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate
por: Lee, Sang-Won, et al.
Publicado: (2012) -
Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis
por: Salem, Heba F., et al.
Publicado: (2022) -
Increased Encapsulation Efficiency of Methotrexate in Liposomes for Rheumatoid Arthritis Therapy
por: Guimarães, Diana, et al.
Publicado: (2020) -
Primary Hepatic Lymphoma in a Patient with Rheumatoid Arthritis Treated with Methotrexate
por: Tatsumi, Goichi, et al.
Publicado: (2014)